Pimecrolimus 1% Cream for Hyperplastic Type Vulvar Dystrophy in Postmenopausal Diabetic Women: A Case Series

摘要

A trial of safer therapeutic option in treatment of hyperplastic type vulvar dystrophy of postmenopausal diabetic women CASE SERIES: In this case series, the efficacy of twice-daily application of pimecrolimus 1 % cream in four postmenopausal who suffered from hyperplastic type vulvar dystrophy was investigated. After two months treatment, all women had almost complete clinical remission including relief from itch, pain and inflammation. No significant side effects have been observed